胰腺癌患者手术前后PRDM14、IGFBP2水平与微血管密度的关系

摘要/Abstract

摘要： 目的分析胰腺癌患者进行根治性外科切除手术前和手术后PRDM14、IGFBP2水平变化及与微血管密度的关系。方法选取2017年1月~2023年12月期间在延边大学附属医院进行根治性外科切除手术的100例胰腺癌患者作为研究对象,使用流式细胞仪检测患者手术前和手术后淋巴细胞,酶联免疫吸附法检测患者手术前和手术后S100A9、MMP-9、PRDM14、IGFBP2水平,Pearson相关性分析PRDM14、IGFBP2指标与胰腺癌的相关性与微血管密度的关系。ROC曲线分析PRDM14、IGFBP2对胰腺癌患者微血管密度的预测价值。结果胰腺癌患者在进行根治性外科切除手术后,其S100A9、MMP-9、PRDM14、IGFBP2水平呈降低趋势,淋巴细胞水平显著升高（P<0.05）;微血管密度与性别、年龄和肿瘤部位无关,与肿瘤直径、分化程度、TNM分期、淋巴结转移相关,其中,低分化组的微血管密度显著高于中分化组和高分化组,中分化组的微血管密度比高分化组高;淋巴结转移组的微血管密度显著高于淋巴结未转移组,具有统计学差异（P<0.05）。Spearman相关性分析显示,PRDM14、IGFBP2表达与胰腺癌患者微血管密度均呈正相关,具有统计学差异（P<0.05）。ROC分析显示,联合诊断高于PRDM14、IGFBP2单项诊断,具有统计学差异（P<0.05）。结论 PRDM14、IGFBP2水平在胰腺癌患者行根治性外科切除手术后呈降低趋势,PRDM14、IGFBP2水平与微血管密度呈正相关。

关键词: 胰腺癌, 根治性外科切除手术, 正性调节区锌指蛋白14, 胰岛素样生长因子结合蛋白2, 微血管密度

Abstract: Objective To analyze the changes of PRDM14 and IGFBP2 levels and their relationship with microvascular density in patients with pancreatic cancer before and after radical surgical resection. Methods Choose from January 2017 to December 2023 in Yanbian University Hospital during radical surgical resection surgery, 100 cases of pancreatic cancer patients as the research object, using flow cytometry instrument testing before and after operation in patients with lymphocytes,Enzyme-linked immunosorbent assay was used to detect the levels of S100A9, MMP-9, PRDM14 and IGFBP2 before and after surgery. Pearson correlation analysis was used to analyze the relationship between PRDM14, IGFBP2 and pancreatic cancer and microvessel density. ROC curve was applied to analyze the predictive value of PRDM14 and IGFBP2 for microvascular density in patients with pancreatic cancer. Results After radical surgical resection, the levels of S100A9, MMP-9, PRDM14 and IGFBP2 were decreased, while the levels of lymphocytes were significantly increased (P<0.05). The microvascular density was not related to sex, age and tumor location, but was related to tumor diameter, differentiation degree, TNM stage and lymph node metastasis. The microvascular density in the low-differentiated group was significantly higher than that in the medium-differentiated group and the highly differentiated group, and the microvascular density in the medium-differentiated group was higher than that in the highly differentiated group. The microvascular density of lymph node metastasis group was significantly higher than that of non-lymph node metastasis group (P<0.05). Spearman correlation analysis showed that the expression of PRDM14 and IGFBP2 were positively correlated with microvascular density in pancreatic cancer patients, with statistical differences (P<0.05). ROC analysis showed that combined diagnosis was higher than single diagnosis of PRDM14 and IGFBP2, with statistical difference (P<0.05). Conclusion The levels of PRDM14 and IGFBP2 showed a decreasing trend after radical surgical resection, and the levels of PRDM14 and IGFBP2 were positively correlated with microvascular density.

Key words: Pancreatic cancer, Radical surgical resection, Positive regulatory zone zinc finger protein 14, Insulin-like growth factor binding protein 2, Microvessel density

中图分类号:

R735.9

张文杰, 戴军. 胰腺癌患者手术前后PRDM14、IGFBP2水平与微血管密度的关系[J]. 承德医学院学报, 2024, 41(5): 377-381.

ZHANG Wen-jie, DAI Jun. Relationship between PRDM14, IGFBP2 Levels and Microvascular Density in Patients with Pancreatic Cancer before and after Surgery[J]. Journal of Chengde Medical University, 2024, 41(5): 377-381.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: http://tougao.cdmc.edu.cn:8088/CN/

http://tougao.cdmc.edu.cn:8088/CN/Y2024/V41/I5/377

参考文献

[1] 朱琳熙,毛谅,杜娟,等. 胰腺癌新辅助转化治疗后根治性切除术的临床疗效[J]. 中华消化外科杂志,2023,22(7):916-923.
[2] 蔡正华,杨翼飞,伏旭,等. 术前CT图像评估人体成分在预测胰腺癌术后并发症中的价值[J]. 腹部外科,2022,35(5):332-337.
[3] Sung H, Ferlay J, Siegel RL, et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[4] 邢颖,李有国,郑建伟,等. 胰腺癌联合血管重建手术要点[J]. 中国临床医生杂志,2023,51(6):636-639.
[5] 张海燕,吴红芳,王静,等. 胰腺癌组织中星形胶质细胞上调基因-1、性别决定区Y框蛋白2的表达及与患者临床特征和微血管密度的关系[J]. 癌症进展,2022,20(7):668-671.
[6] 梁刚,王智翔,何盟国,等. Slit2、Robo1蛋白在胰腺癌组织中的表达及其与微血管密度的关系[J]. 医学临床研究,2020,37(1):95-97.
[7] 中华人民共和国国家卫生健康委员会医政医管局. 胰腺癌诊疗指南(2022年版)[J]. 中华消化外科杂志,2022,21(9):1117-1136.
[8] Kim M, Ly SH, Xie Y, et al.YAP1 and PRDM14 converge to promote cell survival and tumorigenesis[J]. Dev Cell, 2022, 57(2): 212-227.
[9] 陈柯帆,陆运鑫,莫苑君,等. PRDM14在胰腺癌组织中的表达及对肿瘤干细胞迁移的影响[J]. 山西医科大学学报,2020,51(2):129-133.
[10] Imai K, Taniguchi H.Therapeutic siRNA targeting the cancer cell stemness regulator PRDI-BF1 and RIZ domain zinc finger protein 14[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2022, 98(7): 325-335.
[11] He S, Ma X, Zheng N, et al.PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells[J]. Mol Med Rep, 2021, 23(2): 149.
[12] Kasprzak A.Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer[J]. Int J Mol Sci, 2021, 22(12): 6434.
[13] 郑双华,王泽夏,刘菲,等. 人胶质瘤中胰岛素样生长因子结合蛋白2表达与功能[J]. 武汉大学学报(医学版),2020,41(1):52-57.
[14] Guo Q, Yu DY, Yang ZF, et al.IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway[J]. Dig Liver Dis, 2020, 52(5): 573-581.
[15] Taniguchi H, Natori Y, Miyagi Y, et al.Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex[J]. Int J Cancer, 2021, 149(3): 646-656.
[16] 卢熹微,刘娇,曹军丽. CTC检测联合CA199、IGFBP2检测对胰腺癌的诊断价值[J]. 中国实验诊断学,2022,26(8):1141-1144.
[17] 付德利,杜新月,李明山. MSCT灌注成像参数对胰腺癌鉴别诊断效果及与肿瘤恶性生物学行为、微血管密度的关系[J]. 影像科学与光化学,2020,38(4):718-723.
[18] Battistella A, Partelli S, Andreasi V, et al.Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)[J]. Surgery, 2022, 172(4): 1236-1244.
[19] Anannamcharoen S, Boonya-Ussadorn C, Nimmanon T.Tissue Microvessel Density as a Potential Predictive Marker for Vascular Invasion in Colorectal Cancer[J]. Asian Pac J Cancer Prev, 2023, 24(12): 4097-4102.
[20] Tian J, Liu Y, Zhang TL, et al.Clinical significance of LAG-3 on microvessel density in primary hepatocellular carcinoma[J]. Indian J Pathol Microbiol, 2022, 65(3): 581-588.